DiaMedica Therapeutics (DMAC) Net Margin (2018)
DiaMedica Therapeutics' Net Margin history spans 1 years, with the latest figure at 277.4% for Q3 2018.
- For Q3 2018, Net Margin changed N/A year-over-year to 277.4%; the TTM value through Jun 2019 reached 1814.0%, changed N/A, while the annual FY2025 figure was 3530.0%, 7542412.0% down from the prior year.
- Net Margin reached 277.4% in Q3 2018 per DMAC's latest filing.
- In the past five years, Net Margin ranged from a high of 277.4% in Q3 2018 to a low of 277.4% in Q3 2018.